Insider Transactions

What SEALSQ Corp's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	3	37
Total trades	8	50

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

Common stock only — 50 reported trades in the last 12 months are in a security these totals do not cover.

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Enguent Jean-Pierre	Vice President, R&DSS	Sep 03	Disclosed 10b5-1 sale · S	−15,000	$2.40	−$36K	0
Enguent Jean-Pierre	Vice President, R&DSS	Sep 01	Exercise / conversion · M	+15,000	$0.01	+$150	15,000
Enguent Jean-Pierre	Vice President, R&DSS	Aug 05	Disclosed 10b5-1 sale · S	−15,000	$2.46	−$36.9K	0
Enguent Jean-Pierre	Vice President, R&DSS	Aug 03	Exercise / conversion · M	+15,000	$0.01	+$150	15,000
Enguent Jean-Pierre	Vice President, R&DSS	Jul 08	Disclosed 10b5-1 sale · S	−15,000	$2.82	−$42.3K	0
Enguent Jean-Pierre	Vice President, R&DSS	Jul 06	Exercise / conversion · M	+15,000	$0.01	+$150	15,000
Ward Peter	Director	Jun 16	Withheld — tax / exercise cost · F	−96,530	$3.07	−$296K	270,531
Ward Peter	Director	Jun 16	Exercise / conversion · M	+366,746	$0.01	+$3.67K	367,061
Moreira Carlos	Chief Executive Officer	Jun 05	Disclosed 10b5-1 sale · S	−300	$3.51	−$1.05K	696,215
O'Hara John Charles	Chief Financial Officer	Jun 05	Disclosed 10b5-1 sale · S	−143	$3.51	−$502	250,431
Moreira Carlos	Chief Executive Officer	Jun 03	Disclosed 10b5-1 sale · S	−7,005	$3.53	−$24.7K	696,515
O'Hara John Charles	Chief Financial Officer	Jun 03	Disclosed 10b5-1 sale · S	−5,582	$3.53	−$19.7K	250,574
Enguent Jean-Pierre	Vice President, R&DSS	Jun 03	Disclosed 10b5-1 sale · S	−15,000	$3.51	−$52.7K	0
Moreira Carlos	Chief Executive Officer	Jun 02	Disclosed 10b5-1 sale · S	−10,000	$3.69	−$36.9K	703,520
O'Hara John Charles	Chief Financial Officer	Jun 02	Disclosed 10b5-1 sale · S	−10,000	$3.69	−$36.9K	256,156
Enguent Jean-Pierre	Vice President, R&DSS	Jun 01	Exercise / conversion · M	+15,000	$0.01	+$150	15,000
Moreira Carlos	Chief Executive Officer	May 29	Disclosed 10b5-1 sale · S	−10,000	$3.51	−$35.1K	713,520
O'Hara John Charles	Chief Financial Officer	May 29	Disclosed 10b5-1 sale · S	−10,000	$3.51	−$35.1K	266,156
Moreira Carlos	Chief Executive Officer	May 27	Disclosed 10b5-1 sale · S	−4,139	$3.50	−$14.5K	723,520
O'Hara John Charles	Chief Financial Officer	May 27	Disclosed 10b5-1 sale · S	−4,689	$3.50	−$16.4K	276,156

Page 1 of 3 · showing the 20 most recent Sign up free to view all 50 transactions and filter by insider →